The aim of chemotherapy is to kill cancer cells, often by directly targeting cell growth cycles, while doing the least possible damage to normal cells. Cancer cells can form a lump or mass that keeps getting bigger and bigger (local spread) and can also travel to other parts of the body through the lymphatic system and bloodstream (metastatic spread).
Examples of chemotherapy agents available in Aotearoa New Zealand
The tables below list some examples of currently funded chemotherapy agents available in Aotearoa New Zealand.
These chemotherapy agents can be used alone or in combination with other chemotherapy agents, medicines or treatments that increase the effectiveness of the chemotherapy agent or help prevent side effects.
Read more about:
Oral chemotherapy agents
The table below lists some examples of funded chemotherapy agents taken by mouth (orally), that are available in Aotearoa New Zealand, and used as treatments for our country's most common cancers.
Name of medicine (brand name) |
Class of oral chemotherapy agent |
alectinib (Alecensa®) | Tyrosine kinase inhibitor |
capecitabine (Viatris®) | Antimetabolite |
cyclophosphamide (Cyclonex®) | Alkylating agent |
etoposide (Vepesid®) | Topoisomerase II inhibitor |
hydroxycarbamide (hydroxyurea) (Devatis®) | Antimetabolite |
imatinib (Rex®) | Protein kinase inhibitor |
irinotecan (Accord®, Actavis®, Rex®) | Topoisomerase I inhibitor |
methotrexate (Trexate®) | Antimetabolite |
midostaurin (Rydapt®) | Tyrosine kinase inhibitor |
niraparib (Zejula®) | Poly (ADP-ribose) polymerase (PARP) inhibitor |
palbociclib (Ibrance®) | Protein kinase inhibitor |
ribociclib (Kisqali®) | Tyrosine kinase inhibitor |
temozolamide (Temaccord®, Apo®, Accord®) |
Alkylating agent |
vinorelbine (Te Arai®) | Vinca alkaloid |
Intravenous (IV) chemotherapy agents
The table below lists some examples of funded chemotherapy agents given intravenously (through a vein), that are available in Aotearoa New Zealand, and used as treatments in our country's most common cancers.
Name of medicine | Class of IV chemotherapy agent |
atezolizumab (Tecentriq®) | Immune checkpoint inhibitor |
bendamustine (Ribomustin®, Sandoz®, Baxter®) | Alkylating agent |
carboplatin (Carbaccord®, Ebewe®, DBL®) | Platinum compound |
cisplatin (Ebewe®, DBL®) | Platinum compound |
cetuximab (Erbitux®) | Epidermal growth factor receptor inhibitor |
cyclophosphamide (Cytoxan®, Endoxan®) | Alkylating agent |
dacarbazine (APP®, DBL®) | Alkylating agent |
docetaxel (Accord)®, Sandoz®, DBL®) | Taxane |
doxorubicin (Accord®, Ebewe®, Arrow®) |
Anthracycline |
durvalumab (Imfinzi®) | Immune checkpoint inhibitor |
epirubicin (Ebewe®) | Anthracycline |
etoposide (Etopophos®, Rex®) | Topoisomerase II inhibitor |
fluorouracil (also called 5FU) (Accord®) | Antimetabolite |
gemcitabine (DBL®, Ebewe®) | Antimetabolite |
methotrexate (DBL®, Sandoz®, Ebewe®) | Antimetabolite |
nivolumab (Opdivo®) | Immune checkpoint inhibitor |
oxaliplatin (Accord®, Alchemy®, Ebewe®) | Platinum compound |
paclitaxel (Anzatax®, Actavis®, Ebewe®) | Taxane |
pembrolizumab (Keytruda®) | Immune checkpoint inhibitor |
pemetrexed | Antimetabolite |
trastuzumab (Herzuma® [PDF, 85 KB]) | Immune checkpoint inhibitor |
trastuzumab emtansine (Kadcyla®) | Immune checkpoint inhibitor |
vinblastine (DBL®) | Vinca alkaloid |
vinorelbine (Navelbine®, Ebewe®, Sagent®) | Vinca alkaloid |